HK1100290A1 - Heterocyclic condensed compounds useful as antidiuretic agents - Google Patents
Heterocyclic condensed compounds useful as antidiuretic agentsInfo
- Publication number
- HK1100290A1 HK1100290A1 HK07108386.8A HK07108386A HK1100290A1 HK 1100290 A1 HK1100290 A1 HK 1100290A1 HK 07108386 A HK07108386 A HK 07108386A HK 1100290 A1 HK1100290 A1 HK 1100290A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- compounds useful
- antidiuretic agents
- heterocyclic condensed
- condensed compounds
- antidiuretic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60289004P | 2004-08-20 | 2004-08-20 | |
| EP04104006A EP1627876A1 (en) | 2004-08-20 | 2004-08-20 | Heterocyclic condensed compounds useful as antidiuretic agents |
| PCT/EP2005/054081 WO2006018443A1 (en) | 2004-08-20 | 2005-08-18 | Heterocyclic condensed compounds useful as antidiuretic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1100290A1 true HK1100290A1 (en) | 2007-09-14 |
Family
ID=34929464
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK07108386.8A HK1100290A1 (en) | 2004-08-20 | 2007-08-01 | Heterocyclic condensed compounds useful as antidiuretic agents |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US8063038B2 (xx) |
| EP (2) | EP1627876A1 (xx) |
| JP (1) | JP4705105B2 (xx) |
| KR (1) | KR100877336B1 (xx) |
| CN (1) | CN1968947A (xx) |
| AT (1) | ATE457026T1 (xx) |
| AU (1) | AU2005273875B2 (xx) |
| CA (1) | CA2567782A1 (xx) |
| CY (1) | CY1110619T1 (xx) |
| DE (1) | DE602005019241D1 (xx) |
| DK (1) | DK1778677T3 (xx) |
| ES (1) | ES2339786T3 (xx) |
| HK (1) | HK1100290A1 (xx) |
| HR (1) | HRP20100250T1 (xx) |
| IL (1) | IL178839A0 (xx) |
| MX (1) | MX2007001861A (xx) |
| NO (1) | NO20071476L (xx) |
| PL (1) | PL1778677T3 (xx) |
| PT (1) | PT1778677E (xx) |
| RU (1) | RU2359969C2 (xx) |
| SI (1) | SI1778677T1 (xx) |
| WO (1) | WO2006018443A1 (xx) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0000079D0 (en) * | 2000-01-05 | 2000-02-23 | Ferring Bv | Novel antidiuretic agents |
| EP1632494A1 (en) | 2004-08-24 | 2006-03-08 | Ferring B.V. | Vasopressin v1a antagonists |
| MX2009011923A (es) | 2007-05-10 | 2009-11-18 | Amr Technology Inc | Tetrahidrobenzo-1,4-diazepinas aril- y heteroaril-sustituidas y uso de las mismas para bloquear reabsorcion de norepinefrina, dopamina y serotonina. |
| US9447049B2 (en) | 2010-03-01 | 2016-09-20 | University Of Tennessee Research Foundation | Compounds for treatment of cancer |
| PT3289876T (pt) | 2008-06-16 | 2022-10-28 | Univ Tennessee Res Found | Compostos para o tratamento do câncer |
| US9029408B2 (en) | 2008-06-16 | 2015-05-12 | Gtx, Inc. | Compounds for treatment of cancer |
| JP5368556B2 (ja) | 2008-07-16 | 2013-12-18 | エフ．ホフマン−ラ ロシュ アーゲー | 心臓血管疾患の処置のための新規ヘテロシクリル化合物 |
| WO2011005842A1 (en) | 2009-07-09 | 2011-01-13 | Gilead Sciences, Inc. | Anti-rsv compounds |
| JP2011057661A (ja) * | 2009-08-14 | 2011-03-24 | Bayer Cropscience Ag | 殺虫性カルボキサミド類 |
| RU2581367C2 (ru) | 2010-03-01 | 2016-04-20 | Джи Ти Икс, ИНК. | Соединения для лечения рака |
| US9119878B2 (en) | 2010-07-08 | 2015-09-01 | Wellesley Pharmaceuticals, Llc | Extended-release formulation for reducing the frequency of urination and method of use thereof |
| KR20140108675A (ko) * | 2012-01-04 | 2014-09-12 | 웰즐리 파마슈티컬스 엘엘씨 | 배뇨 빈도를 감소시키기 위한 연장-방출형 제제 및 이의 사용 방법 |
| WO2013103389A1 (en) * | 2012-01-04 | 2013-07-11 | Wellesley Pharmaceuticals, Llc | Delayed-release formulation for reducing the frequency of urination and method of use thereof |
| EP2612663A1 (en) * | 2012-01-04 | 2013-07-10 | Wellesley Pharmaceuticals, LLC | Extended-release formulation for reducing the frequency of urination and method of use thereof |
| EP2612662B1 (en) * | 2012-01-04 | 2020-03-04 | Wellesley Pharmaceuticals, LLC | Delayed-release formulation for reducing the frequency of urination and method of use thereof |
| SG11201500408VA (en) * | 2012-03-19 | 2015-03-30 | Wellesley Pharmaceuticals Llc | Extended-release formulation for reducing the frequency of urination and method of use thereof |
| US10596127B2 (en) | 2013-03-14 | 2020-03-24 | Wellesley Pharmaceuticals, Llc | Composition for reducing the frequency of urination, method of making and use thereof |
| EP3015451B1 (en) * | 2013-06-25 | 2018-01-17 | Kumiai Chemical Industry Co., Ltd. | Method for producing nitrobenzene compound |
| CN106810508B (zh) * | 2017-01-05 | 2019-12-10 | 浙江农林大学暨阳学院 | 一种铁催化多组分反应合成苯并[1,4]-氧氮杂卓化合物的方法 |
| WO2019003433A1 (ja) * | 2017-06-30 | 2019-01-03 | 大塚製薬株式会社 | ベンゾアゼピン誘導体 |
| CN114853728B (zh) * | 2022-05-07 | 2023-11-07 | 四川制药制剂有限公司 | 一种富马酸伏诺拉生片及其制备方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0015601D0 (en) * | 2000-06-26 | 2000-08-16 | Ferring Bv | Novel antidiuretic agents |
-
2004
- 2004-08-20 EP EP04104006A patent/EP1627876A1/en not_active Withdrawn
-
2005
- 2005-08-18 RU RU2007101237/04A patent/RU2359969C2/ru not_active IP Right Cessation
- 2005-08-18 PT PT05781746T patent/PT1778677E/pt unknown
- 2005-08-18 EP EP05781746A patent/EP1778677B1/en active Active
- 2005-08-18 ES ES05781746T patent/ES2339786T3/es active Active
- 2005-08-18 CA CA002567782A patent/CA2567782A1/en not_active Abandoned
- 2005-08-18 AT AT05781746T patent/ATE457026T1/de active
- 2005-08-18 PL PL05781746T patent/PL1778677T3/pl unknown
- 2005-08-18 SI SI200530930T patent/SI1778677T1/sl unknown
- 2005-08-18 AU AU2005273875A patent/AU2005273875B2/en not_active Ceased
- 2005-08-18 MX MX2007001861A patent/MX2007001861A/es active IP Right Grant
- 2005-08-18 WO PCT/EP2005/054081 patent/WO2006018443A1/en active Application Filing
- 2005-08-18 JP JP2007526462A patent/JP4705105B2/ja not_active Expired - Fee Related
- 2005-08-18 DK DK05781746.2T patent/DK1778677T3/da active
- 2005-08-18 CN CNA2005800192975A patent/CN1968947A/zh active Pending
- 2005-08-18 KR KR1020077002387A patent/KR100877336B1/ko not_active IP Right Cessation
- 2005-08-18 US US11/660,207 patent/US8063038B2/en not_active Expired - Fee Related
- 2005-08-18 DE DE602005019241T patent/DE602005019241D1/de active Active
-
2006
- 2006-10-24 IL IL178839A patent/IL178839A0/en unknown
-
2007
- 2007-03-19 NO NO20071476A patent/NO20071476L/no not_active Application Discontinuation
- 2007-08-01 HK HK07108386.8A patent/HK1100290A1/xx not_active IP Right Cessation
-
2010
- 2010-04-26 CY CY20101100370T patent/CY1110619T1/el unknown
- 2010-05-03 HR HR20100250T patent/HRP20100250T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2359969C2 (ru) | 2009-06-27 |
| EP1627876A1 (en) | 2006-02-22 |
| CN1968947A (zh) | 2007-05-23 |
| AU2005273875A1 (en) | 2006-02-23 |
| AU2005273875B2 (en) | 2009-08-27 |
| WO2006018443A1 (en) | 2006-02-23 |
| ES2339786T3 (es) | 2010-05-25 |
| DE602005019241D1 (de) | 2010-03-25 |
| CY1110619T1 (el) | 2015-04-29 |
| KR20070027761A (ko) | 2007-03-09 |
| SI1778677T1 (sl) | 2010-09-30 |
| KR100877336B1 (ko) | 2009-01-07 |
| HRP20100250T1 (hr) | 2010-06-30 |
| DK1778677T3 (da) | 2010-04-19 |
| JP2008509972A (ja) | 2008-04-03 |
| EP1778677A1 (en) | 2007-05-02 |
| CA2567782A1 (en) | 2006-02-23 |
| ATE457026T1 (de) | 2010-02-15 |
| IL178839A0 (en) | 2007-03-08 |
| PL1778677T3 (pl) | 2010-07-30 |
| PT1778677E (pt) | 2010-03-17 |
| US20080234250A1 (en) | 2008-09-25 |
| EP1778677B1 (en) | 2010-02-03 |
| JP4705105B2 (ja) | 2011-06-22 |
| NO20071476L (no) | 2007-03-19 |
| US8063038B2 (en) | 2011-11-22 |
| RU2007101237A (ru) | 2008-09-27 |
| MX2007001861A (es) | 2007-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL178839A0 (en) | Heterocyclic condensed compounds useful as antidiuretic agents | |
| HU0400405D0 (en) | Novel compounds | |
| EA200301073A1 (ru) | N-(2-арилэтил)бензиламины в качестве антагонистов 5-ht-рецептора | |
| WO2006021213A3 (en) | Vasopressin v1a antagonists | |
| EA200301121A1 (ru) | Тартраты 5,8,14-триазатетрацикло[10.3.1.02,11.04,9]гексадека-2(11),3,5,7,9-пентаена | |
| BG108650A (en) | Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease | |
| CY1112402T1 (el) | Ενισχυτες υποδοχεων γλουταμικου | |
| CR20140316A (es) | Derivados de indol como antagonistas receptores de s1p1 (divisional 10922) | |
| TNSN07235A1 (en) | Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride | |
| GB0510143D0 (en) | Novel compounds A1 | |
| EP1804919A4 (en) | CGRP RECEPTOR ANTAGONISTS | |
| EP1615914A4 (en) | CGRP RECEPTOR ANTAGONISTS | |
| TW200714587A (en) | Biphenyl compounds useful as muscarinic receptor antagonists | |
| MX2008002805A (es) | Derivados de carboxamida como antagonistas del receptor muscarinico. | |
| MXPA03006605A (es) | Esteres de indol-5-ilo del acido bencensulfonico como antagonistas del receptor 5-ht6. | |
| TW200745039A (en) | Isotopically substituted pantoprazole | |
| EA200400454A1 (ru) | Мускариновые агонисты | |
| EA200701881A1 (ru) | 1,3-тиазол-5-карбоксамиды, используемые в качестве противораковых химиотерапевтических агентов | |
| MXPA05011430A (es) | Compuestos lineares basicos antagonistas de nk-2 y formulaciones que los contienen. | |
| FR2874920A1 (fr) | Derives de 3-spiro-indolin-2-one comme ligand des recepteurs de la vasopressine | |
| UA89846C2 (ru) | Производные карбоксамида как антагонисты мускариновых рецепторов |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20140818 |